Mind and Skin - the neurocutaneous axis in atopic eczema v1
Research type
Research Study
Full title
‘Mind & Skin’: A prospective cohort study evaluating the impact of inflammation, itch and sleep disturbance on the brain, mental health and cognition, in patients with severe atopy.
IRAS ID
280154
Contact name
Carsten Flohr
Contact email
Sponsor organisation
King’s College London
Duration of Study in the UK
1 years, 5 months, 31 days
Research summary
Atopic eczema is an intensely itchy skin disease which often starts in infancy or early childhood. It can have profound effects on patients’ quality of life and cause long-lasting psychological impairment. Sleep may be very disturbed. More severe disease often requires oral/injectable immuno-modulatory treatments (i.e. medications which control symptoms by influencing the immune system).
There is an association between eczema, impaired cognitive functioning and mental health disorders, but the underlying mechanisms are not clearly defined.
This projects examines the links between inflammation-driven itching and disturbed sleep, and how this might be causally responsible for systemic and brain inflammation, disturbance of cognitive functioning and mental health problems. We will also study potential changes occurring following an improvement in eczema when patients are treated with systemic immuno-modulators.
Key investigations will include:
i) Home-based sleep studies using a commercially available sleep devices (for example DREEM headband, Philips Actiwatch, oximetry)
ii) Structural and functional magnetic resonance imaging (MRI) of the brain,
iii) Blood tests to quantify systemic inflammation
iv) Genetic analyses, particularly related to the immune system, circadian rhythm (the “internal 24-hour clock”), skin barrier function and the risk of developing eczema or associated diseases,
v) Assessments of the skin’s barrier function
vi) Stool samples and skin swabs to study the gut and skin microbiome.We will utilise existing anonymised data for comparative purposes (e.g. from patients with Attention Deficit Hyperactivity Disorder (ADHD) and healthy controls who previously had brain imaging.)
We will explore eczema patients’ and families’ perception of their disease, in particular itch and the resulting sleep loss, through focus groups, to better understand the sociological impact of eczema, and how these patients’ interactions with the external world and society are affected by eczema. Importantly, this will include exploration of family dynamics, as patients with eczema often have profound sleep disturbance from early life, which can impact on their caregivers’ sleep and quality of life.
REC name
London - Harrow Research Ethics Committee
REC reference
22/PR/0016
Date of REC Opinion
25 Mar 2022
REC opinion
Further Information Favourable Opinion